Progress of comprehensive geriatric assessment in elderly patients with hematologic malignancies / 白血病·淋巴瘤

ABSTRACT

The incidence of hematologic malignancies in elderly is increasing year by year. So for clinicians, it is a problem to assess the tolerance to chemotherapy of elderly patients with hematological cancer. Recently, the comprehensive geriatric assessment has begun to be used in elderly patients with hematological malignancies. The studies have found that the comprehensive geriatric assessment could be used to assess the prognosis, predict the patient's tolerance to treatment, and may also be used as guidelines for making treatment decision. This paper mainly reviews the research status of comprehensive geriatric assessment in elderly patients with hematological malignancies at home and abroad.